| Description | Taprenepag (CP-544326) (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM). Taprenepag has been used in trials studying the treatment of Ocular Hypertension and Glaucoma, Open-Angle. |
| Target activity | Prostaglandin E2:2.8 nM(EC50) |
| Synonyms | CP-544326 |
| molecular weight | 478.52 |
| Molecular formula | C24H22N4O5S |
| CAS | 752187-80-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 55 mg/mL (114.94 mM) |
| References | 1. Prasanna G, et al. Exp Eye Res. 2011 Sep;93(3):256-64. |